Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
HRTX

Market Cap: $60.23M

HI

Heron Therapeutics, Inc.

HRTX

NASDAQ (NASDAQ Capital Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin70.07%

EBITDA Margin-18.42%

EBIT Margin-19.94%

Pre-tax Margin-22.52%

Net Profit Margin-22.52%

Earnings Yield-56.22%

Valuation Multiples

Price / Book8.77

Price / Sales0.40

Price / Earnings-1.70

PEG0.01

Forward PEG0.11

EV / Sales1.24

EV / EBITDA-6.75

EV / Operating Cash Flow-16.19

EV / Free Cash Flow-15.48

Price / Free Cash Flow-4.96

Price / Operating Cash Flow-5.22

Cash Flow & Capital

Free Cash Flow / Share-$0.06

Operating Cash Flow / Share-$0.06

Free Cash Flow Yield-20.15%

Capex / Revenue0.35%

Capex / Operating Cash Flow-4.56%

Capex / Depreciation0.25

Stock Compensation / Revenue7.40%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.49

Quick Ratio1.51

Cash Ratio0.22

Debt / Assets0.59

Debt / Capital0.96

Debt / Equity21.48

Long-Term Debt / Capital0.95

Debt / Market Cap2.37%

Net Debt / EBITDA-4.58

Solvency Ratio-0.13

Financial Leverage36.52

Efficiency & Working Capital

Asset Turnover0.60

Fixed Asset Turnover8.68

Inventory Turnover0.50

Receivables Turnover1.69

Payables Turnover3.89

Days Sales Outstanding216.26

Days Inventory Outstanding730.8

Days Payables Outstanding93.91

Operating Cycle947.06

Cash Conversion Cycle853.14

Working Capital Turnover1.09

Returns & Quality

Return on Equity-3.01%

Return on Assets-13.50%

Return on Invested Capital-6.78%

ROCE-6.79%

Return on Tangible Assets-13.50%

Operating Return on Assets-4.36%

Income Quality0.34

Tax Burden1.00

Interest Burden1.13

Balance Sheet & Intrinsic Metrics

Enterprise Value$187.86M

Invested Capital$155.11M

Working Capital$137.7M

Tangible Asset Value$6.91M

Net Current Asset Value$-15.51M

Graham Net-Net-$0.47

Book Value / Share$0.04

Tangible Book Value / Share$0.04

Cash / Share$0.22

Financial Health Scores

Piotroski Score2

Altman Z-Score-9.83

Revenue$151.18M

EBIT$-30.15M

Market Cap$60.23M

Working Capital$137.7M

Retained Earnings$-1.95B

Total Assets$252.26M

Total Liabilities$245.35M